Cargando…
Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice.
Several investigators including ourselves have shown that hydralazine can potentiate the anti-tumour activity of certain agents against murine tumours probably by manipulating tumour blood flow. In order to investigate the effects of administration of hydralazine on systemic and tumour drug concentr...
Autores principales: | Bibby, M. C., Loadman, P. M., al-Ghabban, A. F., Double, J. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977609/ https://www.ncbi.nlm.nih.gov/pubmed/1558786 |
Ejemplares similares
-
Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon.
por: Double, J. A., et al.
Publicado: (1986) -
Activity of a new nitrosourea (TCNU) in human lung cancer xenografts.
por: Fergusson, R. J., et al.
Publicado: (1988) -
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.
por: Quinn, P. K., et al.
Publicado: (1992) -
Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512).
por: Bibby, M. C., et al.
Publicado: (1988) -
Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).
por: Bibby, M. C., et al.
Publicado: (1987)